Abiraterone Acetate (AA) in pre- and post-docetaxel (DX) metastatic castration resistant prostate cancer (mCRPC): a monoinstitutional experience focused on cardiovascular (CV) events

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION(2017)

引用 0|浏览4
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要